Albuquerque, N.M.-based Kingfisher Americas has applied for FDA approval to market KFH Energy, a device used to relieve pain and fatigue in patients with chronic diseases. The device, which uses Bio-Electric Stimulation Therapy, was unveiled in Europe in September, and is expected to get U.S. regulatory clearance by January.

Related Summaries